list of fda approved glp-1 receptor agonists What to know about the new era drugs GLP-1 Receptor Agonists List: Complete
Description
Davies said several GLP-1/glucagon dual agonists have moved on to phase 2 or phase 3 trials, including survodutide (Boehringer Ingelheim), efinopegdutide (Hanmi Pharmaceutical), mazdutide (Eli Lilly and Innovent) and pemvidutide (Altimmune)

doi: 10.1007/s12020-020-02588-8 [DOI] [PubMed] [Google Scholar] 42

Nauck MA, Quast DR, Wefers J, Meier JJ (2021) GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art

Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors

Semaglutide, the active ingredient in Novo Nordisks Ozempic and Wegovy, has been in short supply since March 2022 amid the drugs surging popularity
